Telogen Effluvium

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-23
Clinical Trial Update: Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists [NA]
An update on an ongoing trial evaluating a drinkable nutraceutical for hair loss in patients using GLP-1/GIP receptor agonists (Telogen Effl…